Stay updated on ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial
Sign up to get notified when there's something new on the ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial page.

Latest updates to the ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedFooter now displays Revision: v3.3.3, and the HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedFooter revision updated from v3.3.1 to v3.3.2. No study data or page content was altered.SummaryDifference0.1%

- Check42 days agoChange DetectedPublication notes were updated to indicate that publications are automatically filled from PubMed and may not be about the study. The revision label changed from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoval of the government funding/operating status notice from the page. Core study information such as eligibility criteria, endpoints, and study results remains unchanged.SummaryDifference0.4%

- Check63 days agoChange DetectedNo additions or deletions were detected on the page. The study details and layout appear unchanged.SummaryDifference0.3%

- Check92 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.SummaryDifference3%

Stay in the know with updates to ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial page.